Propel Bio Management

Propel Bio Management as of June 30, 2026

Portfolio Holdings for Propel Bio Management

Propel Bio Management holds 29 positions in its portfolio as reported in the June 2026 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Plains Gp Holdings Lp-cl Comm (PAGP) 16.2 $31M 1.3M 24.27
Achieve Life Sciences Comm (ACHV) 13.8 $26M 4.0M 6.53
Corcept Therapeutics Comm (CORT) 6.2 $12M 137k 86.95
Phathom Pharmaceuticals I Comm (PHAT) 6.0 $11M 1.1M 10.85
Delcath Systems Comm (DCTH) 5.7 $11M 872k 12.59
Milestone Pharmaceuticals Comm (MIST) 5.2 $10M 7.4M 1.34
Compass Pathways Adrs (CMPS) 4.2 $8.1M 573k 14.15
Kyverna Therapeutics Comm (KYTX) 4.1 $7.9M 883k 8.91
Artiva Biotherapeutics In Comm (ARTV) 3.5 $6.8M 696k 9.70
Abeona Therapeutics Comm (ABEO) 3.2 $6.1M 983k 6.18
Aquestive Therapeutics In Comm (AQST) 3.1 $6.0M 1.4M 4.16
Palisade Bio Comm (PALI) 2.8 $5.4M 2.6M 2.09
Immunic Comm (IMUX) 2.6 $5.0M 325k 15.37
Inventiva Sa - Comm (IVA) 2.5 $4.8M 1.3M 3.78
Sab Biotherapeutics Comm (SABS) 2.2 $4.2M 1.1M 3.90
Orchestra Biomed Holdings Comm (OBIO) 2.0 $3.9M 897k 4.32
Celldex Therapeutics Comm (CLDX) 2.0 $3.9M 104k 37.21
Zevra Therapeutics Comm (ZVRA) 1.9 $3.6M 254k 14.34
Ocular Therapeutix Comm (OCUL) 1.8 $3.5M 358k 9.82
4d Molecular Therapeutics In Comm (FDMT) 1.8 $3.4M 253k 13.30
Ovid Therapeutics Comm (OVID) 1.6 $3.0M 1.1M 2.69
Eyepoint Comm (EYPT) 1.4 $2.7M 192k 14.30
Upstream Bio Comm (UPB) 1.3 $2.4M 350k 6.92
Scynexis Comm 1.2 $2.2M 544k 4.07
Silence Therapeutics Adrs (SLN) 1.1 $2.1M 192k 10.98
Leonabio Comm (LONA) 0.7 $1.4M 149k 9.19
Maze Therapeutics Comm (MAZE) 0.7 $1.3M 44k 29.84
Corvus Pharmaceuticals Comm (CRVS) 0.6 $1.1M 70k 14.94
Sagimet Biosciences Inc-a Comm (SGMT) 0.5 $973k 126k 7.73